AAV producer cell lines: Learning from mAbs
Get insights on how mAb production has evolved — and what it means for viral vectors.
Cell lines to help accelerate your therapeutic journey
Cell lines play a vital role in therapeutic production by providing a consistent and scalable source of biological materials essential for developing and manufacturing treatments. These cell lines can be engineered to produce high yields, ensuring the quality and efficacy of the final product. Cytiva offers solutions for protein, monoclonal antibody (mAb), and viral vector production through its GOCHO platform and ELEVECTA™ cell line portfolio, helping you accelerate your therapeutic journey.
Resources
Performant transient cell line with higher quality
Learn how we obtain efficient and scalable production of rAAVs across multiple serotypes with low levels of encapsidated hcDNA.
Developing GOCHO™ platform
A robust cell line development platform relies on a host cell line; learn more about our platform.
